Unknown

Dataset Information

0

Heme interacts with c1q and inhibits the classical complement pathway.


ABSTRACT: C1q is the recognition subunit of the first component of the classical complement pathway. It participates in clearance of immune complexes and apoptotic cells as well as in defense against pathogens. Inappropriate activation of the complement contributes to cellular and tissue damage in different pathologies, urging the need for the development of therapeutic agents that are able to inhibit the complement system. In this study, we report heme as an inhibitor of C1q. Exposure of C1q to heme significantly reduced the activation of the classical complement pathway, mediated by C-reactive protein (CRP) and IgG. Interaction analyses revealed that heme reduces the binding of C1q to CRP and IgG. Furthermore, we demonstrated that the inhibition of C1q interactions results from a direct binding of heme to C1q. Formation of complex of heme with C1q caused changes in the mechanism of recognition of IgG and CRP. Taken together, our data suggest that heme is a natural negative regulator of the classical complement pathway at the level of C1q. Heme may play a role at sites of excessive tissue damage and hemolysis where large amounts of free heme are released.

SUBMITTER: Roumenina LT 

PROVIDER: S-EPMC3091251 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Heme interacts with c1q and inhibits the classical complement pathway.

Roumenina Lubka T LT   Radanova Maria M   Atanasov Boris P BP   Popov Krastio T KT   Kaveri Srinivas V SV   Lacroix-Desmazes Sébastien S   Frémeaux-Bacchi Véronique V   Dimitrov Jordan D JD  

The Journal of biological chemistry 20110322 18


C1q is the recognition subunit of the first component of the classical complement pathway. It participates in clearance of immune complexes and apoptotic cells as well as in defense against pathogens. Inappropriate activation of the complement contributes to cellular and tissue damage in different pathologies, urging the need for the development of therapeutic agents that are able to inhibit the complement system. In this study, we report heme as an inhibitor of C1q. Exposure of C1q to heme sign  ...[more]

Similar Datasets

| S-EPMC6931381 | biostudies-literature
| S-EPMC9270254 | biostudies-literature
| S-EPMC454176 | biostudies-literature
| S-EPMC7396675 | biostudies-literature
| S-EPMC7267003 | biostudies-literature
| S-EPMC4725857 | biostudies-literature
| S-EPMC8794146 | biostudies-literature
| S-EPMC10351459 | biostudies-literature
| S-EPMC6102844 | biostudies-literature
| S-EPMC9641935 | biostudies-literature